Drug
nivolumab
2 HCP commentary reports on clinical trials studying nivolumab. Each report covers what clinicians said in public about one trial, with the source behind every view.
| Trial | Indication | Phase | Claims | HCP sources | Size | Updated | Preview |
|---|---|---|---|---|---|---|---|
| CheckMate 744 NCT02927769 · Bristol-Myers Squibb | Hodgkin lymphoma | Phase 2 | 197 | 19 | Standard | 2026-10-09 | Preview |
| NEONIPIGA NCT04006262 · GERCOR - Multidisciplinary Oncology Cooperative Group | Gastroesophageal adenocarcinoma | Phase 2 | 1,222 | 60 | Deep | 2026-10-08 | Preview |